Search for 'an:"297" and au:Serna Torroba, Javier de la'

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.

By Serna Torroba, Javier de la . Leukemia & lymphoma, 2015 . 56(3):656-62. , Formato Vancouver: Ferrà C, Sanz J, Díaz Pérez MA, Morgades M, Gayoso J, Cabrera JR et al; Grupo Español de Trasplante Hematopoyético (Geth) Spanish Society of Hematology. Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. Leuk Lymphoma. 2015 Mar;56(3):656-62.

Place Hold on Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

By Serna Torroba, Javier de la . Annals of hematology, 2015 . 94(8):1347-56. , Formato Vancouver: Sanz MA, Montesinos P, Kim HT, Ruiz Argüelles GJ, Undurraga MS, Uriarte MR et al; IC-APL and PETHEMA and HOVON Groups. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Ann Hematol. 2015 Aug;94(8):1347-56.

Place Hold on All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

Clinical Utility of the Collect Scale To Assess Comorbidities In Patients With Chronic Lymphocytic Leukemia.

By Serna Torroba, Javier de la . Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2014 . 17(7):A522. , Formato Vancouver: De la Serna J, Carbonell F, Giraldo P, López A, González I, García C et al. Clinical Utility of the Collect Scale To Assess Comorbidities In Patients With Chronic Lymphocytic Leukemia. Value Health. 2014 Nov;17(7):A522.

Place Hold on Clinical Utility of the Collect Scale To Assess Comorbidities In Patients With Chronic Lymphocytic Leukemia.

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome.

By Serna Torroba, Javier de la . Leukemia Research, 2013 . 37(7):769-76. , Formato Vancouver: Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, Arenillas L, Valcarcel D, Vallespí T et al. Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome. Leuk Res. 2013 Jul;37(7):769-76.

Place Hold on Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome.

Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.

By Serna Torroba, Javier de la . Revista española de quimioterapia: publicación oficial de la Sociedad Española de Quimioterapia, 2013 . 26(1):64-9. , Formato Vancouver: De la Serna J, Jarque I, López-Jiménez J, Fernández-Navarro JM, Gómez V, Jurado M et al. Tratamiento de infecciones fúngicas en pacientes hematológicos de alto riesgo. La respuesta de AmBisome no se modifica con el uso previo de azoles de amplio espectro. Rev Esp Quimioter. 2013 Mar;26(1):64-9.

Place Hold on Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.

Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome.

By Serna Torroba, Javier de la . Journal of Clinical Oncology, 2013 . 31(7):916-22. , Formato Vancouver: Valcárcel D, Ademà V, Solé F, Ortega M, Nomdedeu B, Sanz G et al. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome. J Clin Oncol. 2013 Mar 1;31(7):916-22.

Place Hold on Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome.

Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.

By Serna Torroba, Javier de la . British Journal of Haematology, 2012 . 157(1):67-74. , Formato Vancouver: Delgado J, Espinet B, Oliveira AC, Abrisqueta P, de la Serna J, Collado R, et al. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results. Br J Haematol. 2012 Apr;157(1):67-74.

Place Hold on Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03)

By Serna Torroba, Javier de la | Martínez López, Joaquín. Leukemia and Lymphoma, 2011 . 52(3):409-416. , Formato Vancouver: Tomás JF, Montalbán C, De Sevilla AF, Martínez-López J, Díaz N, Canales M, et al. Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03). Leuk Lymphoma. 2011;52(3):409-16.

Place Hold on Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03)

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

By Serna Torroba, Javier de la . Expert Review of Hematology, 2011 . 4(1):9-16. , Formato Vancouver: Vallejo C, Ríos E, de la Serna J, Jarque I, Ferrá C, Sánchez-Godoy P, et al. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab. Expert Rev Hematol. 2011;4(1):9-16.

Place Hold on Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

Infiltrative cervical lesions causing symptomatic occipital neuralgia

By Hernández Gallego, Jesús | Martínez Salio, Antonio | Morales Cartagena, Cristina Alejandra | Ruiz Giménez, J. | Serna Torroba, Javier de la | Sierra Hidalgo, Fernando. Cephalalgia, 2011 . 31(14):1493-1496. , Formato Vancouver: Sierra-Hidalgo F, Ruíz J, Morales-Cartagena A, Martínez-Salio A, Serna JL, Hernández-Gallego J. Infiltrative cervical lesions causing symptomatic occipital neuralgia. Cephalalgia. 2011;31(14):1493-6.

Place Hold on Infiltrative cervical lesions causing symptomatic occipital neuralgia

Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma

By Serna Torroba, Javier de la | Martínez López, Joaquín | Rapado Martínez, Inmaculada | Rivero Ruiz, Ana. Leukemia Research, 2011 . 35(4):431-437. , Formato Vancouver: Rivero A, Rapado I, Tomás JF, Montalbán C, De Oña R, Paz Carreira J, et al. Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. Leuk Res. 2011;35(4):431-7.

Place Hold on Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

By Serna Torroba, Javier de la . Blood, 2011 . 117(6):1799-1805. , Formato Vancouver: Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, et al. Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Blood. 2011;117(6):1799-805.

Place Hold on Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage

By Serna Torroba, Javier de la . Blood Cells Molecules and Diseases, 2011 . 46(1):115-118. , Formato Vancouver: Giraldo P, Irún P, Alfonso P, Dalmau J, Fernández Galán MA, Figueredo A, et al. Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage. Blood Cells Mol Dis. 2011 Jan 15;46(1):115-8.

Place Hold on Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage

Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica

By Serna Torroba, Javier de la | Gilsanz Rodríguez, Florinda. Gaceta Sanitaria, 2011 . 25(4):274-281. , Formato Vancouver: Casado LF, García Marco JA, Gilsanz F, González M, Ríos E, de la Serna J, et al. Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica. Gac Sanit. 2011 Jul-Aug;25(4):274-81.

Place Hold on Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica

Leucoencefalopatía multifocal progresiva en un paciente con leucemia mieloide aguda sometido a trasplante alogénico de progenitores hematopoyéticos

By Serna Torroba, Javier de la | Fernández Ruiz, Mario | López Medrano, Francisco | Ruiz Morales, Juan Manuel. Enfermedades Infecciosas y Microbiología Clínica, 2011 . 29(8):636-637. , Formato Vancouver: Fernández-Ruiz M, de la Serna J, Ruiz J, López-Medrano F. Leucoencefalopatía multifocal progresiva en un paciente con leucemia mieloide aguda sometido a trasplante alogénico de progenitores hematopoyéticos. Enferm Infecc Microbiol Clin. 2011 Oct;29(8):636-7.

Place Hold on Leucoencefalopatía multifocal progresiva en un paciente con leucemia mieloide aguda sometido a trasplante alogénico de progenitores hematopoyéticos